Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Pedro Beltran currently holds 44,576 shares of BridgeBio Oncology Therapeutics, Inc. (BBOT), valued at approximately $0. This represents their equity stake as Chief Scientific Officer.
Based on SEC Form 4 filings, Pedro Beltran has been a net neutral trader of BBOT stock. They have purchased $0 and sold $0 worth of shares.
Pedro Beltran's most recent insider trade was on Jul 1, 2026, when they sold 1,047 shares at $7.80 per share.
Pedro Beltran serves as Chief Scientific Officer at BridgeBio Oncology Therapeutics, Inc. (BBOT). They have executed 4 insider transactions totaling $0 over their tenure at the company.
Pedro Beltran holds the position of Chief Scientific Officer at BridgeBio Oncology Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Pedro Beltran has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Pedro Beltran was on Apr 1, 2026, when they sold $9.5K worth of BBOT shares. This transaction involved 1,047 shares at $9.03 per share.
Pedro Beltran currently owns 44,576 shares of BridgeBio Oncology Therapeutics, Inc. (BBOT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Pedro Beltran's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Pedro Beltran has 4 Form 4 filings on record as an insider at BridgeBio Oncology Therapeutics, Inc..
Set alerts for Pedro Beltran and 40,000+ other insiders.